WordNet

(medicine) any sensation or change in bodily function that is experienced by a patient and is associated with a particular disease
anything that accompanies X and is regarded as an indication of Xs existence
a bag that fills with air
a distensible membranous sac (usually containing liquid or gas) (同)vesica

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 膀胱癌の臨床症状、診断、および病期分類 clinical presentation diagnosis and staging of bladder cancer
2. 膀胱腫瘍の病理 pathology of bladder neoplasms
3. 男性における下部尿路症状 lower urinary tract symptoms in men
4. 非尿路上皮膀胱癌 non urothelial bladder cancer
5. 尿路上皮（移行上皮）膀胱癌の疫学および病因 epidemiology and etiology of urothelial transitional cell carcinoma of the bladder

[Intrarenal bacillus Calmette-Guerin therapy for carcinoma in situ of the upper urinary tract].

Okubo K1, Ishitoya S, Maeda H, Suzuki Y, Arai Y.
Nihon Hinyōkika Gakkai zasshi. The japanese journal of urology.Nihon Hinyokika Gakkai Zasshi.1997 Mar;88(3):386-90.
PURPOSE: We performed intrarenal bacillus Calmette-Guerin (BCG) instillation for carcinoma in situ (CIS) of the upper urinary tract. Its efficacy and safety are evaluated.MATERIAL AND METHODS: Eight patients (6 men and 2 women, median age of 63.7 years) diagnosed as upper urinary tract carcinoma in
PMID 9125861

[Impact of bladder irritative symptoms and detrusor instability on the outcome of urethropexy].

Virseda Chamorro M1, Salinas Casado J, Ramírez Fernández JC, Rapariz González M, Esteban Fuertes M, Nacarino Corbacho L, Resel Estévez L.
Archivos españoles de urología.Arch Esp Urol.1995 Jul-Aug;48(6):595-601.
OBJECTIVES: To evaluate the repercussion of irritative urinary symptoms and bladder instability on the results of urethropexy for urinary stress incontinence.METHODS: A clinical and urodynamic study was carried out in 70 adult women submitted to urethropexy (Kelly, Raz, Marshall-Marchetti-Krantz, Bu
PMID 7661637

大久保和俊,石戸谷哲,前田浩,鈴木裕志,荒井陽一
日本泌尿器科學會雜誌 88(3), 386-390, 1997-03-20
(目的)上部尿路上皮内癌には確立された治療法がない。今回上部尿路上皮内癌に対し積極的にBCG腎盂内注入療法を行いその効果を検討した。(方法)1993年8月より1996年1月までに上部尿路上皮内癌と診断した8例9晋を対象とした。診断基準は1)自排尿の細胞診が陽性,2)膀胱,尿道の多部位生検で上皮内癌を認めない。3)尿路造影で上部尿路に異常がない,4)腎盂尿細胞診が同一側で2回以上連続で陽性,のすべて …
NAID 110003088940